RE-BVS – Piemonte Repository

Sfoglia per AUTORE
POTT C
Collezione AOU Alessandria

Items : 7

Addition of autologous stem-cell transplantation to an ibrutinib-containing first-line treatment in patients aged 18-65 years with mantle cell lymphoma (TRIANGLE): 4·5-year follow-up of a three-arm, randomised, open-label, phase 3 superiority trial of the European MCL Network. in Lancet (London, England) / Lancet. 2026 May 16;407(10542):1953-1967. doi: 10.1016/S0140-6736(26)00362-4.

2026
AOU Alessandria

Herhaus P; Wirths S; Meerten TV; Heß G; Jachimowicz RD; Kerkhoff A; Stilgenbauer S; Jiang L; Leppä S; da Silva MG; Shpilberg O; Vergote VKJ; Trneny M; Riise J; Mey U; Hutchings M; Walewski J; Jerkeman M; Giné E; Doorduijn J; Dreyling M; Hoster E; Ladetto M; Tix T; Unterhalt M; Schmidt C; Klapper W; Pott C; Stefani PM; et alii...

Rituximab Maintenance Added to Ibrutinib-Containing Therapy in Younger, Untreated Patients With Mantle Cell Lymphoma: Results From the TRIANGLE Trial. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2026 Jul 14:JCO2600705. doi: 10.1200/JCO-26-00705.

2026
AOU Alessandria

Ladetto M; Gutmair K; Tavarozzi R; Pawlikowski A; Schomaker M; Doorduijn J; Giné E; Jerkeman M; Walewski J; Hutchings M; Mey U; Riise J; Trneny M; Vergote VKJ; Horowitz NA; Gomes da Silva M; Leppä S; Jiang L; Stilgenbauer S; Kerkhoff A; Jachimowicz RD; Heß G; van Meerten T; Wirths S; Herhaus P; Novak U; Dierlamm J; Hänel M; Hanoun C; et alii...

Noninvasive genotyping and early disease dynamics demonstrate the efficacy of ibrutinib in combination with immunochemotherapy in patients with mantle cell lymphoma treated in the TRIANGLE trial. in Leukemia / Leukemia. 2026 Jan;40(1):95-105. doi: 10.1038/s41375-025-02787-0. Epub 2025 Nov 3.

2026
AOU Alessandria

Ladetto M; Brüggemann M; Baldus CD; Giné E; Visco C; Gameiro P; Doorduijn J; da Silva MG; Medina Herrera A; van der Velden VHJ; Homburg CHE; Sanz RG; Verhagen OJHM; Laqua A; Alessandria B; Ferrero S; Genuardi E; Khouja M; Schmidt C; Dreyling M; Jiang L; Hoster E; Darzentas N; Pal K; Chitadze G; Stewart JP; Gonzalez D; Pott C;

Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network. in Lancet (London, England) / Lancet. 2024 May 25;403(10441):2293-2306. doi: 10.1016/S0140-6736(24)00184-3. Epub 2024 May 2.

2024
AOU Alessandria

Dreyling M; Doorduijn J; Giné E; Jerkeman M; Walewski J; Hutchings M; Mey U; Riise J; Trneny M; Vergote V; Shpilberg O; Gomes da Silva M; Leppä S; Jiang L; Stilgenbauer S; Kerkhoff A; Jachimowicz RD; Celli M; Hess G; Arcaini L; Visco C; van Meerten T; Wirths S; Zinzani PL; Novak U; Herhaus P; Benedetti F; Sonnevi K; Hanoun C; et alii...

Quality Assessment for PCR-based Minimal Residual Disease in Lymphoma: 10 Years of Cross-laboratory Standardization Process Within the Fondazione Italiana Linfomi MRD Network. in HemaSphere / Hemasphere. 2021 Sep 6;5(10):e639. doi: 10.1097/HS9.0000000000000639. eCollection 2021 Oct.

2021
AOU Alessandria
AOU Città della Salute di Torino

Gaidano G; Del Giudice I; Galimberti S; Gattei V; Agostinelli C; García-Sanz R; Delfau-Larue MH; Pott C; Alessandria B; Degan M; Bomben R; Gazzola A; Mannu C; Cavalli M; De Novi LA; Ciabatti E; Grassi S; Della Starza I; Ferrante M; Genuardi E; Mantoan B; Ladetto M; Ferrero S; Drandi D;

Minimal Residual Disease in Mantle Cell Lymphoma: Methods and Clinical Significance. in Hematology/oncology clinics of North America / Hematol Oncol Clin North Am. 2020 Oct;34(5):887-901. doi: 10.1016/j.hoc.2020.06.006. Epub 2020 Aug 5

2020
AOU Alessandria

Ladetto M; Tavarozzi R; Pott C;

Droplet Digital PCR Quantification of Mantle Cell Lymphoma Follow-up Samples From Four Prospective Trials of the European MCL Network. in HemaSphere / Hemasphere. 2020 Apr 3;4(2):e347. doi: 10.1097/HS9.0000000000000347. eCollection 2020 Apr.

2020
AOU Alessandria
AOU Città della Salute di Torino

Hermine O; Dreyling M; Cortelazzo S; Ribrag V; Eckert C; Abdo C; Callanan M; Jimenez C; Ciabatti E; Bomben R; Starza ID; Cheminant M; Villarese P; Mantoan B; Genuardi E; Ferrante M; Zaccaria G; Lhermitte L; Söhlbrandt A; Benmaad I; Alcantara M; Drandi D; Delfau-Larue MH; Pott C; Ladetto M; Ferrero S; Macintyre E;